Literature DB >> 29362226

ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.

Nermin M Kady1, Xuwen Liu2, Todd A Lydic1, Meesum H Syed1, Svetlana Navitskaya1, Qi Wang1, Sandra S Hammer1, Sandra O'Reilly1, Chao Huang1, Sergey S Seregin3, Andrea Amalfitano3, Vince A Chiodo4, Sanford L Boye4, William W Hauswirth4, David A Antonetti2, Julia V Busik5.   

Abstract

Tight junctions (TJs) involve close apposition of transmembrane proteins between cells. Although TJ proteins have been studied in detail, the role of lipids is largely unknown. We addressed the role of very long-chain (VLC ≥26) ceramides in TJs using diabetes-induced loss of the blood-retinal barrier as a model. VLC fatty acids that incorporate into VLC ceramides are produced by elongase elongation of very long-chain fatty acids protein 4 (ELOVL4). ELOVL4 is significantly reduced in the diabetic retina. Overexpression of ELOVL4 significantly decreased basal permeability, inhibited vascular endothelial growth factor (VEGF)- and interleukin-1β-induced permeability, and prevented VEGF-induced decrease in occludin expression and border staining of TJ proteins ZO-1 and claudin-5. Intravitreal delivery of AAV2-hELOVL4 reduced diabetes-induced increase in vascular permeability. Ultrastructure and lipidomic analysis revealed that ω-linked acyl-VLC ceramides colocalize with TJ complexes. Overall, normalization of retinal ELOVL4 expression could prevent blood-retinal barrier dysregulation in diabetic retinopathy through an increase in VLC ceramides and stabilization of TJs.
© 2018 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29362226      PMCID: PMC5860862          DOI: 10.2337/db17-1034

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  55 in total

1.  Characterization of mouse orthologue of ELOVL4: genomic organization and spatial and temporal expression.

Authors:  Md Nawajes A Mandal; Rajesh Ambasudhan; Paul W Wong; Philip J Gage; Paul A Sieving; Radha Ayyagari
Journal:  Genomics       Date:  2004-04       Impact factor: 5.736

2.  Evidence for the lipidic nature of tight junction strands.

Authors:  B Kachar; T S Reese
Journal:  Nature       Date:  1982-04-01       Impact factor: 49.962

3.  Epidermal expression of an Elovl4 transgene rescues neonatal lethality of homozygous Stargardt disease-3 mice.

Authors:  Anne McMahon; Igor A Butovich; Wojciech Kedzierski
Journal:  J Lipid Res       Date:  2011-03-22       Impact factor: 5.922

4.  Effects of ischemic preconditioning and bevacizumab on apoptosis and vascular permeability following retinal ischemia-reperfusion injury.

Authors:  Steven F Abcouwer; Cheng-mao Lin; Ellen B Wolpert; Sumathi Shanmugam; Eric W Schaefer; Willard M Freeman; Alistair J Barber; David A Antonetti
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-06-16       Impact factor: 4.799

5.  Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy.

Authors:  Maria Enge; Mattias Bjarnegård; Holger Gerhardt; Erika Gustafsson; Mattias Kalén; Noomi Asker; Hans-Peter Hammes; Moshe Shani; Reinhardt Fässler; Christer Betsholtz
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

6.  Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration.

Authors:  G Karan; C Lillo; Z Yang; D J Cameron; K G Locke; Y Zhao; S Thirumalaichary; C Li; D G Birch; H R Vollmer-Snarr; D S Williams; K Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-04       Impact factor: 11.205

7.  Regulation of hepatic fatty acid elongase and desaturase expression in diabetes and obesity.

Authors:  Yun Wang; Daniela Botolin; Jinghua Xu; Barbara Christian; Ernestine Mitchell; Bolleddula Jayaprakasam; Muraleedharan G Nair; Muraleedharan Nair; Jeffrey M Peters; Jeffery M Peters; Julia V Busik; Julia Busik; L Karl Olson; Donald B Jump
Journal:  J Lipid Res       Date:  2006-06-21       Impact factor: 5.922

8.  Quantifying transduction efficiencies of unmodified and tyrosine capsid mutant AAV vectors in vitro using two ocular cell lines.

Authors:  Renee C Ryals; Sanford L Boye; Astra Dinculescu; William W Hauswirth; Shannon E Boye
Journal:  Mol Vis       Date:  2011-04-29       Impact factor: 2.367

9.  Depletion of ceramides with very long chain fatty acids causes defective skin permeability barrier function, and neonatal lethality in ELOVL4 deficient mice.

Authors:  Wenmei Li; Roger Sandhoff; Mari Kono; Patricia Zerfas; Vickie Hoffmann; Bryan Char-Hoa Ding; Richard L Proia; Chu-Xia Deng
Journal:  Int J Biol Sci       Date:  2007-02-06       Impact factor: 6.580

10.  Remodeling of retinal Fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4.

Authors:  Maria Tikhonenko; Todd A Lydic; Yun Wang; Weiqin Chen; Madalina Opreanu; Andrew Sochacki; Kelly M McSorley; Rebecca L Renis; Timothy Kern; Donald B Jump; Gavin E Reid; Julia V Busik
Journal:  Diabetes       Date:  2009-10-29       Impact factor: 9.461

View more
  15 in total

Review 1.  New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism.

Authors:  Stephanie Eid; Kelli M Sas; Steven F Abcouwer; Eva L Feldman; Thomas W Gardner; Subramaniam Pennathur; Patrice E Fort
Journal:  Diabetologia       Date:  2019-07-25       Impact factor: 10.122

2.  n-3 PUFA Supplementation Alters Retinal Very-Long-Chain-PUFA Levels and Ratios in Diabetic Animal Models.

Authors:  Aruna Gorusupudi; Fu-Yen Chang; Kelly Nelson; Gregory S Hageman; Paul S Bernstein
Journal:  Mol Nutr Food Res       Date:  2019-06-28       Impact factor: 5.914

3.  Deletion of the stress-response protein REDD1 promotes ceramide-induced retinal cell death and JNK activation.

Authors:  Weiwei Dai; William P Miller; Allyson L Toro; Adam J Black; Sadie K Dierschke; Robert P Feehan; Scot R Kimball; Michael D Dennis
Journal:  FASEB J       Date:  2018-06-19       Impact factor: 5.191

Review 4.  Emerging Insights and Interventions for Diabetic Retinopathy.

Authors:  Avinash Honasoge; Eric Nudleman; Morton Smith; Rithwick Rajagopal
Journal:  Curr Diab Rep       Date:  2019-09-10       Impact factor: 4.810

Review 5.  Role of ceramides in the pathogenesis of diabetes mellitus and its complications.

Authors:  Nawajes Mandal; Richard Grambergs; Koushik Mondal; Sandip K Basu; Faiza Tahia; Sam Dagogo-Jack
Journal:  J Diabetes Complications       Date:  2020-09-16       Impact factor: 2.852

Review 6.  Current understanding of the molecular and cellular pathology of diabetic retinopathy.

Authors:  David A Antonetti; Paolo S Silva; Alan W Stitt
Journal:  Nat Rev Endocrinol       Date:  2021-01-19       Impact factor: 47.564

7.  trans-2-Enoyl-CoA Reductase Tecr-Driven Lipid Metabolism in Endothelial Cells Protects against Transcytosis to Maintain Blood-Brain Barrier Homeostasis.

Authors:  Jinxuan Wang; Jianxiong Xu; Guangchao Zang; Tao Zhang; Qi Wu; Hongping Zhang; Yidan Chen; Yi Wang; Weixi Qin; Shuang Zhao; Erdai Qin; Juhui Qiu; Xiaojuan Zhang; Lin Wen; Yeqi Wang; Guixue Wang
Journal:  Research (Wash D C)       Date:  2022-04-04

8.  Plasma Exosomes Contribute to Microvascular Damage in Diabetic Retinopathy by Activating the Classical Complement Pathway.

Authors:  Chao Huang; Kiera P Fisher; Sandra S Hammer; Svetlana Navitskaya; Gary J Blanchard; Julia V Busik
Journal:  Diabetes       Date:  2018-06-04       Impact factor: 9.461

9.  Mitochondrial Ceramide Effects on the Retinal Pigment Epithelium in Diabetes.

Authors:  Yan Levitsky; Sandra S Hammer; Kiera P Fisher; Chao Huang; Travan L Gentles; David J Pegouske; Caimin Xi; Todd A Lydic; Julia V Busik; Denis A Proshlyakov
Journal:  Int J Mol Sci       Date:  2020-05-28       Impact factor: 5.923

Review 10.  Diabetic photoreceptors: Mechanisms underlying changes in structure and function.

Authors:  Silke Becker; Lara S Carroll; Frans Vinberg
Journal:  Vis Neurosci       Date:  2020-10-06       Impact factor: 3.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.